Home › Novel Hydrogel Sealant And Sustained Release Drug Technology Data To Be Presented At The ASCRS Annual Symposium
 

Keywords :   


Novel Hydrogel Sealant And Sustained Release Drug Technology Data To Be Presented At The ASCRS Annual Symposium

2014-04-21 10:33:31| chemicalonline News Articles

Ocular Therapeutix, Inc., developers of ophthalmic therapeutic products using a proprietary hydrogel technology, has announced that 11 podium and poster presentations, including clinical data on its ReSure Sealant and sustained release dexamethasone, will be presented at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium in Boston, Massachusetts from April 25-29, 2014

Tags: the data technology release

Category:Chemicals

Latest from this category

All news
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
17.05Dutch Boy Paints Introduces Professional Series at Menards
17.05RadTech 2024 Sustainability Award Winners are Selected
17.05BYK-Gardner USA Launches New Dispermat Dissolver CV3evo
17.05BASF Ranks 22 on Fair360 list of Top 50 Companies for Diversity
17.05Nisar Amin Named Regional Sales Manager at JNS-SmithChem
17.05PNWSCT Coatings Fest 2024 Issues Call for Papers
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
Chemicals »
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »